Gd- NEDA individuals experienced a rise of the numbers of this subset after ocrelizumab treatment (p=0
Gd- NEDA individuals experienced a rise of the numbers of this subset after ocrelizumab treatment (p=0.013, Supplementary Table?2). presence [Gd+, n=16] or absence [Gd-, n=53]… Read More »Gd- NEDA individuals experienced a rise of the numbers of this subset after ocrelizumab treatment (p=0